Femtogenix, a UK biotechnology company developing the next generation of DNA-interactive Antibody Drug Conjugate (ADC) payloads, announced data demonstrating the potent efficacy and favourable toxicity profile of a reduced potency analogue from its Pyridinobenzodiazepine (PDD) […]
Sanofi has received the European Commission (EC) approval for Dupixent (dupilumab) to treat adults with severe chronic rhinosinusitis with nasal polyposis. The approval allows the use of the drug alongside intranasal corticosteroids for patients who […]
Gilead Sciences and Glympse Bio announced that the companies have entered into a strategic collaboration in nonalcoholic steatohepatitis (NASH) clinical development. Glympse Bio’s proprietary synthetic biomarkers – bioengineered to identify stage and progression of disease […]
Enesi Pharma has received funding from the Bill & Melinda Gates Foundation to develop and assess solid dose vaccines for measles and rubella using its ImplaVax technology platform. Measles is a highly infectious disease that […]
SMi has released an exclusive interview with industry expert Che Connon, Professor of Tissue Engineering at Newcastle University, ahead of the upcoming Ophthalmic Drugs conference which takes place in London on 19th-20th November 2019. As Europe’s […]